0.9775
price up icon10.45%   0.0925
after-market After Hours: .97 -0.0075 -0.77%
loading
Standard Biotools Inc stock is traded at $0.9775, with a volume of 6.11M. It is up +10.45% in the last 24 hours and up +4.81% over the past month. Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
See More
Previous Close:
$0.885
Open:
$0.8861
24h Volume:
6.11M
Relative Volume:
2.90
Market Cap:
$381.29M
Revenue:
$105.90M
Net Income/Loss:
$-61.49M
P/E Ratio:
-4.9569
EPS:
-0.1972
Net Cash Flow:
$-82.65M
1W Performance:
+4.34%
1M Performance:
+4.81%
6M Performance:
-30.18%
1Y Performance:
-15.00%
1-Day Range:
Value
$0.8833
$0.9899
1-Week Range:
Value
$0.8701
$0.9899
52-Week Range:
Value
$0.8701
$1.72

Standard Biotools Inc Stock (LAB) Company Profile

Name
Name
Standard Biotools Inc
Name
Phone
(650) 266-6000
Name
Address
50 MILK STREET, BOSTON
Name
Employee
389
Name
Twitter
Name
Next Earnings Date
2025-02-14
Name
Latest SEC Filings
Name
LAB's Discussions on Twitter

Compare LAB vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
LAB icon
LAB
Standard Biotools Inc
0.9775 345.21M 105.90M -61.49M -82.65M -0.1972
ABT icon
ABT
Abbott Laboratories
101.56 175.59B 44.33B 6.50B 7.40B 3.717
SYK icon
SYK
Stryker Corp
341.24 132.47B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
87.10 113.14B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
64.61 94.85B 20.08B 2.89B 3.66B 1.9391
EW icon
EW
Edwards Lifesciences Corp
78.20 45.09B 6.07B 1.06B 1.34B 1.8063

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-13-25 Downgrade TD Cowen Buy → Hold
Feb-27-25 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-16-24 Initiated TD Cowen Buy
Apr-04-24 Initiated Jefferies Buy
Jul-12-23 Initiated KeyBanc Capital Markets Overweight

Standard Biotools Inc Stock (LAB) Latest News

pulisher
Apr 14, 2026

Standard BioTools (LAB) is One of the Best Life Sciences Penny Stocks, Here is Why - Yahoo Finance UK

Apr 14, 2026
pulisher
Apr 13, 2026

Fundamentals Check: Is Standard BioTools Inc a strong growth stock2026 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

Will Standard BioTools Inc stock hit new highs in YEARWeekly Trading Summary & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 09, 2026

Meme Stocks: Is Standard BioTools Inc impacted by rising ratesQuarterly Earnings Report & Weekly Return Optimization Alerts - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Published on: 2026-04-09 16:18:59 - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 08, 2026

Quarterly Earnings: Is Standard BioTools Inc impacted by rising ratesTrade Entry Report & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Standard BioTools (NASDAQ: LAB) CFO equity awards and tax share withholding - Stock Titan

Apr 08, 2026
pulisher
Apr 07, 2026

Aug Ideas: Should I invest in Standard BioTools Inc before earnings2026 Year in Review & High Accuracy Investment Signals - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 06, 2026

Technical Analysis: Can Standard BioTools Inc stock double in the next yearQuarterly Performance Summary & Momentum Based Trading Signals - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 06, 2026

Aug Setups: How does Standard BioTools Inc correlate with Nasdaq2026 Macro Impact & Community Consensus Stock Picks - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 03, 2026

Standard BioTools (LAB) Price Target Decreased by 12.68% to 1.58 - MSN

Apr 03, 2026
pulisher
Apr 02, 2026

LAB SEC FilingsSTANDARD BIOTOOLS INC 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026
pulisher
Mar 31, 2026

Can Standard BioTools Inc scale operations efficiently2026 Big Picture & Detailed Earnings Play Strategies - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 30, 2026

Growth Value: Is Standard BioTools Inc impacted by rising rates2026 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Standard BioTools Inc (LAB) Stock Price Quote Today & Current Price Chart - Capital.com

Mar 30, 2026
pulisher
Mar 30, 2026

Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Declines By 18.5% - MarketBeat

Mar 30, 2026
pulisher
Mar 30, 2026

Can Standard BioTools Inc stock double in the next yearCEO Change & Expert Curated Trade Setup Alerts - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 27, 2026

Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. - marketscreener.com

Mar 27, 2026
pulisher
Mar 25, 2026

Downgrade Watch: Will Standard BioTools Inc stock hit new highs in YEAR2026 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 22, 2026

Analysis Recap: Is Standard BioTools Inc impacted by rising rates2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 21, 2026

Earnings Risk: Is Standard BioTools Inc impacted by rising rates2026 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 21, 2026

Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Mar 21, 2026
pulisher
Mar 21, 2026

Pullback Watch: Does Standard BioTools Inc have declining or rising EPSMarket Sentiment Summary & Weekly Return Optimization Plans - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 18, 2026

Whale Trades: Can Standard BioTools Inc stock double in the next yearGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

Long Focus Capital Management LLC Acquires 1,292,804 Shares of Standard BioTools Inc. $LAB - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Standard BioTools Inc. $LAB Shares Purchased by Mak Capital One LLC - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Standard BioTools Inc. 2025 Annual Report: Market Overview, Innovation, and Regulatory Landscape in Life Sciences Tools - Minichart

Mar 17, 2026
pulisher
Mar 16, 2026

Standard BioTools 2025 10-K: Revenue $85.3M, EPS $(0.20) - TradingView

Mar 16, 2026
pulisher
Mar 16, 2026

Standard BioTools (NASDAQ: LAB) refocuses on core tools after SomaScan sale - Stock Titan

Mar 16, 2026
pulisher
Mar 15, 2026

Standard BioTools Inc. $LAB Stake Boosted by Casdin Capital LLC - MarketBeat

Mar 15, 2026
pulisher
Mar 12, 2026

Shorts Report: Can Standard BioTools Inc grow without dilution2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 08, 2026

Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen - MarketBeat

Mar 08, 2026
pulisher
Mar 07, 2026

Retail Trends: Will Standard BioTools Inc stock hit new highs in YEARWeekly Market Report & Fast Momentum Entry Tips - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 07, 2026

Does Standard BioTools Inc have declining or rising EPSJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Aug PostEarnings: Should I invest in Standard BioTools Inc before earningsQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

LAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

LAB Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 03, 2026
pulisher
Mar 03, 2026

AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI

Mar 03, 2026
pulisher
Mar 02, 2026

Eli Casdin boosts equity stake in STANDARD BIOTOOLS (LAB) with 52,991 RSUs - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

STANDARD BIOTOOLS (LAB) director takes 51,282 RSUs in lieu of $60K cash - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Retail Trends: Is Standard BioTools Inc a strong growth stockJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn

Mar 02, 2026
pulisher
Mar 02, 2026

Director at Standard BioTools (LAB) takes RSUs instead of cash pay - Stock Titan

Mar 02, 2026
pulisher
Feb 28, 2026

Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen - marketbeat.com

Feb 28, 2026
pulisher
Feb 27, 2026

Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews

Feb 27, 2026
pulisher
Feb 26, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail

Feb 26, 2026
pulisher
Feb 25, 2026

Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative - Sahm

Feb 25, 2026
pulisher
Feb 25, 2026

Standard BioTools Q4 2025 Results: Profit on $23.8M RevenueNews and Statistics - IndexBox

Feb 25, 2026
pulisher
Feb 24, 2026

Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

Standard BioTools (LAB) Reports Strong Q4 Revenue Exceeding Expe - GuruFocus

Feb 24, 2026
pulisher
Feb 24, 2026

Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beat - ChartMill

Feb 24, 2026
pulisher
Feb 24, 2026

STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax bill - Stock Titan

Feb 24, 2026

Standard Biotools Inc Stock (LAB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Standard Biotools Inc Stock (LAB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kim Hanjoon Alex
Chief Financial Officer
Apr 06 '26
Option Exercise
0.00
70,183
0
2,800,702
Casdin Partners Master Fund, L
Director
Dec 04 '25
Buy
1.45
150,000
217,020
72,100,000
Casdin Partners Master Fund, L
Director
Dec 02 '25
Buy
1.42
125,000
177,512
71,875,000
Casdin Partners Master Fund, L
Director
Dec 03 '25
Buy
1.44
75,000
108,037
71,950,000
Casdin Partners Master Fund, L
Director
Nov 25 '25
Buy
1.30
7,550,000
9,838,405
71,750,000
Casdin Partners Master Fund, L
Director
Nov 24 '25
Buy
1.43
150,000
214,875
64,200,000
Casdin Partners Master Fund, L
Director
Nov 20 '25
Buy
1.30
450,000
586,260
64,050,000
Casdin Partners Master Fund, L
Director
Nov 19 '25
Buy
1.28
350,000
448,910
63,600,000
Casdin Partners Master Fund, L
Director
Nov 18 '25
Buy
1.23
275,000
339,405
63,250,000
Casdin Partners Master Fund, L
Director
Nov 13 '25
Buy
1.20
450,000
541,395
62,500,000
ZBH ZBH
$94.20
price down icon 2.40%
STE STE
$221.50
price down icon 1.48%
$61.54
price down icon 2.24%
PHG PHG
$29.09
price up icon 0.00%
$73.51
price down icon 1.55%
EW EW
$78.20
price up icon 0.00%
Cap:     |  Volume (24h):